EUCAST technical note on isavuconazole breakpoints for Aspergillus, itraconazole breakpoints for Candida and updates for the antifungal susceptibility testing method documents.

Authors :: Arendrup MC
Meletiadis J
Mouton JW
Guinea J
Cuenca-Estrella M
Lagrou K
Howard SJ
Source :: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [Clin Microbiol Infect] 2016 Jun; Vol. 22 (6), pp. 571.e1-4. Date of Electronic Publication: 2016 Feb 03.
Publication Year :: 2016
Abstract: The Subcommittee on Antifungal Susceptibility Testing (AFST) of the ESCMID European Committee for Antimicrobial Susceptibility Testing (EUCAST) has determined breakpoints for isavuconazole and Aspergillus and for itraconazole and Candida spp., released a new document summarizing existing and new minimum inhibitory concentration ranges for quality control strains and revised the method documents for yeast and mould susceptibility testing. This technical note is based on the EUCAST isavuconazole and itraconazole rationale documents, version 1.0 of the routine and extended internal quality control for antifungal susceptibility testing as recommended by EUCAST, and the E.Def 7.3, E.Def 9.2 and E.Def 9.3 method documents (http://www.eucast.org).<br /> (Copyright © 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.)

Subjects :: Quality Control
Antifungal Agents pharmacology
Fungi drug effects
Microbial Sensitivity Tests standards

Language :: English
ISSN :: 1469-0691
Volume :: 22
Issue :: 6
Database :: MEDLINE
Journal :: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Publication Type :: Academic Journal
Accession number :: 26851656
Full Text :: https://doi.org/10.1016/j.cmi.2016.01.017

Full Text Access

Tools